ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema

THURSDAY, Oct. 24, 2024-- For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9, administered as a single...